Edwin Ofori Atta on Permissive Hypertension For Ischemic Stroke
Edwin Ofori Atta, Head Of Pharmacy at Kumasi Hospital, shared on LinkedIn:
”Permissive Hypertension For Ischemic Stroke
In 2026, permissive hypertension remains a standard temporary management strategy for acute ischemic stroke.
It involves intentionally allowing a patient’s blood pressure (BP) to remain elevated to ensure adequate blood flow to the ischemic penumbra—the salvageable brain tissue surrounding the core area of the stroke.
It’s purposely done to maximize cerebral perfusion and promote collateral circulation when the brain’s natural autoregulation of blood flow is impaired.
It’s typically maintained for the first 24hrs to 48hrs following stroke onset.
It’s Primarily candidates are patients with acute ischemic stroke who are not candidates for immediate reperfusion therapies (like “clot-busting” drugs) or those whose BP is high but below dangerous thresholds (<220/120 mmHg)”
Stay updated with Hemostasis Today.
-
Feb 19, 2026, 14:34Favour Kpokpe: Deep Dive Into the Kaggle Stroke Prediction Dataset
-
Feb 19, 2026, 14:28Sam K. Saha: A TIA Is A Warning Shot From A System On The Brink of Failure
-
Feb 19, 2026, 14:23Favour Felix-Ilemhenbhio: Parental Hypoxia Exposure Enhances Offspring Resilience to Stroke
-
Feb 19, 2026, 14:12Bhanu Hima Kumar Gadamsetti: 2018 vs 2026 AHA/ASA Acute Ischemic Stroke Guidelines
-
Feb 19, 2026, 14:10Gonçalo Ferraz Costa: Modern Thrombolytic Strategies and the Risk–Benefit Balance in Valve Thrombosis
-
Feb 19, 2026, 14:07Stéphanie Forté: New Insights on Stroke in Adults with Sickle Cell Disease
-
Feb 19, 2026, 14:00Hugh Kearney: Highlighting the Relevance of the Inflammasome in Multiple Sclerosis Pathophysiology
-
Feb 19, 2026, 13:56Ney Carter Borges: Low-Carbohydrate and Low-Fat Diet Quality and CHD Risk
-
Feb 19, 2026, 13:51Raul Santos: International Collaborative Insights into the Treatment of Homozygous FH